feed,title,long_url,short_url
Barron's,BioMarin Slumps After FDA Rejects Its Hemophilia Gene Therapy,https://www.barrons.com/articles/biomarin-stock-valrox-fda-rejection-hemophilia-gene-therapy-51597853794?mod=RTA,https://j.mp/3hpxjt3
